Neuralink is advancing its efforts to enable participants to control robotic arms using their thoughts, aiming to restore mobility lost due to disease or spinal cord injuries. This initiative is part of ongoing voluntary clinical trials where individuals share their experiences with brain-controlled devices. The latest trial expansion focuses on enhancing autonomy through investigational assistive robotic arms, showcasing how participants can effectively use these brain implants for improved mobility.

Neuralink: Neuralink is a neurotechnology company creating implantable brain-computer interfaces to translate neural signals into actions for controlling computers and external devices. In ongoing clinical trials, participants with ALS or spinal cord injuries are using these investigational implants to restore autonomy through thought-controlled communication and robotic arm operation. The company emphasizes voluntary trial participation to address unmet medical needs like mobility loss.

Clinical Trials: Neuralink devices are investigational, featured in voluntary clinical trials where participants share experiences with brain-controlled device operation.
Trial Expansion: A new feasibility trial extends brain implant capabilities to investigational assistive robotic arms for enhanced autonomy.
Mobility Restoration: Recent demonstrations highlight trial participants using implants to control robotic arms, targeting spinal cord injuries and diseases.